.png)
Total amount raised
$112.5M
Latest funding date
2025-08-10
Location
Truemeds has successfully raised funding through seven rounds, with notable investors including Accel and Peak XV Partners. The company focuses on making healthcare more accessible by offering affordable medicine substitutes and free doctor consultations.
What Is Truemeds?
Truemeds, founded in 2019, is a health-tech startup based in Mumbai, Maharashtra, India. The company operates in the healthcare, medical, pharmaceutical, and telehealth industries, focusing on making healthcare accessible and affordable.
With a significant employee base ranging from 1001 to 5000, Truemeds offers a wide range of prescription and over-the-counter medications, personal care products, and healthcare devices. The platform emphasizes cost savings by recommending branded substitutes that are equally effective but cheaper, along with providing free doctor consultations and fast delivery across India.
How Much Funding Has Truemeds Raised?
- Series C
- Amount Raised: USD 85,000,000 (comprising approximately USD 65,000,000 in primary capital and USD 20,000,000 in secondary transactions; raised in two tranches: Tranche 1 of ~USD 44,000,000 in March 2025 led by Accel, and Tranche 2 of ~USD 20,000,000 primary in July–August 2025 led by Peak XV Partners)
- Date: August 11, 2025 (final close)
- Lead Investors: Accel, Peak XV Partners
- Valuation at Round: Over USD 400,000,000
- Motivation Behind the Round: To expand fulfillment centers in non-metro areas, grow engineering and product teams, open a new Bengaluru office, and triple national penetration in India's generic medicine market.
- Series B
- Amount Raised: USD 22,000,000
- Date: April 2022
- Lead Investors: WestBridge Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the company's growth and pan-India expansion in the health-tech sector.
- Series A
- Amount Raised: USD 5,000,000
- Date: June 2021
- Lead Investors: InfoEdge Ventures, Asha Impact, Indian Angel Network
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance the platform and expand the customer base.
- Seed
- Amount Raised: Approximately USD 487,000 (INR 3.7 Cr)
- Date: May 2020
- Lead Investors: Info Edge Ventures (IE Venture Fund)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To launch the platform and begin operations.
Truemeds has raised a total of at least USD 112,487,000 in disclosed primary funding across all rounds. Including the full USD 85,000,000 Series C (primary + secondary), the total reported figure is approximately USD 135,000,000. The post-Series C valuation is over USD 400,000,000.
Key Investors
- Accel
- Details: Accel is a seed and growth-stage venture capital firm that co-led the Series C Tranche 1 for Truemeds. The firm is known for backing early- and growth-stage technology-driven companies globally.
- Investment Focus Areas: Technology, internet, software
- Notable Investments: Flipkart, Swiggy, Freshworks
- Peak XV Partners
- Details: Peak XV Partners, formerly known as Sequoia India, co-led the Series C Tranche 2 for Truemeds. The firm focuses on investments in high-growth sectors across India and Southeast Asia.
- Investment Focus Areas: Technology, healthcare, consumer
- Notable Investments: Byju's, OYO, Zomato
- WestBridge Capital
- Details: WestBridge Capital led the Series B and participated in the Series C funding rounds of Truemeds. The firm focuses on long-term investments in high-growth sectors.
- Investment Focus Areas: Public and private companies, technology, healthcare
- Notable Investments: Byju's, PolicyBazaar, Delhivery
- Asha Impact
- Details: Asha Impact is an impact investment platform that invested in Truemeds during the Series A round. The firm focuses on investments that generate social and environmental impact.
- Investment Focus Areas: Healthcare, education, financial inclusion
- Notable Investments: Not publicly disclosed
- Info Edge Ventures
- Details: Info Edge Ventures (IE Venture Fund) invested in Truemeds across multiple rounds, including Seed, Series A, and Series C. The firm focuses on internet-based businesses and technology-driven companies.
- Investment Focus Areas: Internet, technology, consumer services
- Notable Investments: Zomato, PolicyBazaar, Naukri.com
What's Next for Truemeds?
Truemeds is poised to capitalize on the rapidly expanding generic medicine market in India, driven by government initiatives to make healthcare more affordable. The company aims to leverage this opportunity by expanding its product offerings in segments like vitamins, supplements, and homeopathic medicines.
Future fundraising opportunities appear promising as Truemeds continues to demonstrate significant revenue growth and market penetration. The company is likely to attract more investors to support its scaling operations and market expansion.
However, Truemeds may face challenges from government-backed pharmacies and fierce competition from other digital health platforms. Managing operational costs while scaling up will be crucial for sustaining growth.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Truemeds and gather other critical business insights.
Sign up for free to start exploring the wealth of information available at your fingertips and drive your sales success to new heights.
